Certain A Shares of ChengDa Pharmaceuticals Co., Ltd. are subject to a Lock-Up Agreement Ending on 20-JAN-2024. These A Shares will be under lockup for 738 days starting from 12-JAN-2022 to 20-JAN-2024.

Details:
The Company?s actual controllers Ge Jianli, Lu Gang, and Lu Jin, shareholder Huang Honglin, and the other directors, supervisors, and senior management not mentioned below committed to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 36 months from the listing date. If within 6 months after the listing, the closing price of the shares is lower than the issuance price for 20 consecutive trading days or if the trading price is lower than the issuance price 6 months after listing, the lock-up period will be automatically extended for another 6 months. While holding office, they committed to transfer not more than 25% of shares held each year.

The Company?s actual controllers? controlled companies that are shareholders Jiashan Huicheng Equity Investment Partnership Enterprise (Limited Partnership) and Jiashan Hecheng Equity Investment Partnership Enterprise (Limited Partnership) committed to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 36 months from the listing date.

The Company?s director Lin Chunzhen and supervisors Guo Linghui and Liu Yanping committed to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 12 months from the listing date. If within 6 months after the listing, the closing price of the shares is lower than the issuance price for 20 consecutive trading days or if the trading price is lower than the issuance price 6 months after listing, the lock-up period will be automatically extended for another 6 months. While holding office, they committed to transfer not more than 25% of shares held each year.

The Company?s shareholders Shenzhen Qianhai Shengtai Investment Enterprise (Limited Partnership), Jiashan Xianhuida Investment Partnership Enterprise (Limited Partnership), Hangzhou Chenghe Shanda Investment Partnership Enterprise (Limited Partnership), Shenzhen Jiuheng Investment Consulting Co., Ltd., Wang Zhe, Jiaxing Mai?erte Equity Investment Partnership Enterprise (Limited Partnership), and Shanghai Fujiurong Enterprise Management Center (Limited Partnership) committed to not transfer or entrust to a third party the Company?s shares they hold directly or indirectly before the issuance, or allow the company to repurchase those shares within 12 months from the listing date.